LEADER 01598nam  2200421 a 450 
001 9910695789703321
005 20070319133805.0
035   $a(CKB)5470000002371880
035   $a(OCoLC)86070784
035   $a(EXLCZ)995470000002371880
100   $a20070319d2006      ua             0
101 0 $aeng
135   $aurmn|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicaid outpatient prescription drugs$b[electronic resource] $eestimated 2007 federal upper limits for reimbursement compared with retail pharmacy acquisition costs
210  1$aWashington, DC :$cU.S. Government Accountability Office,$d[2006]
215   $a29 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Mar. 14, 2007).
300   $aAuthor: John E. Dicken.
300   $a"December 22, 2006."
300   $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
300   $a"GAO-07-239R."
320   $aIncludes bibliographical references.
517   $aMedicaid outpatient prescription drugs 
606   $aMedicaid$xEconomic aspects
606   $aDrugs$xCosts$xGovernment policy$zUnited States
615  0$aMedicaid$xEconomic aspects.
615  0$aDrugs$xCosts$xGovernment policy
700   $aDicken$b John E$01382684
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695789703321
996   $aMedicaid outpatient prescription drugs$93446157
997   $aUNINA